Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 4,400 shares at $38.09 ($168K) on 2024-01-12, disclosed to the SEC on 2024-01-16.
Scheduled sale ($168k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.09 | 2,200 | $84K | 50.0% |
| 2 | $38.09 | 2,200 | $84K | 50.0% |
| Total | $38.09 avg | 4,400 | $168K | 100% |
| Filing → |
| VCEL | SELL | 2024-11-13 | $281K | — | Filing → |
| VCEL | SELL | 2024-03-29 | $338K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |